Home/Filings/4/0001437749-25-000213
4//SEC Filing

DEPASQUALE MICHAEL W 4

Accession 0001437749-25-000213

CIK 0001019034other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:07 PM ET

Size

5.0 KB

Accession

0001437749-25-000213

Insider Transaction Report

Form 4
Period: 2024-12-31
DEPASQUALE MICHAEL W
DirectorPresident & CEO & Director
Transactions
  • Award

    Common Stock

    2024-12-31$1.40/sh+139$19539,519 total
Footnotes (2)
  • [F1]Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023. Holdings do not include options to purchase 464 shares.

Issuer

BIO KEY INTERNATIONAL INC

CIK 0001019034

Entity typeother

Related Parties

1
  • filerCIK 0001246138

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:07 PM ET
Size
5.0 KB